Viral Clearance Market by Method (Viral Removal (Chromatography, Precipitation, and Nanofiltration) and Viral Inactivation (Low pH, Solvent Detergent Method, Pasteurization, and Other Viral Inactivation Methods)), by Application (Blood and Blood Products, Recombinant Proteins, Vaccines, and Other Applications), and by End-User (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, CROs, and Other End-Users): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017–2024

Description

The report covers a forecast and an analysis of the viral clearance market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the viral clearance market along with the impact they have on the demand over the forecast time period. Additionally, the report includes the study of opportunities available in the viral clearance market on global and regional levels.

In order to give the users of this report a comprehensive view of the viral clearance market, we have included a competitive landscape and an analysis of Porter’s Five Forces Model for the market. The study encompasses a market attractiveness analysis, wherein method, application, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the viral clearance market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the viral clearance market on a global and regional basis. 

The study provides a decisive view of the viral clearance market by segmenting the market based on method, application, end-user, and region. The segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The method segment is classified into viral removal and viral inactivation. By application, this market is segmented into blood and blood products, recombinant proteins, vaccines, and other applications. By end-user, this market includes pharmaceutical and biotechnology companies, academic research institutes, contract research organizations (CROs), and other end-users.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further bifurcation into major countries including the U.S. Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes the demand for viral clearance tools based on individual segments and applications in all regions and countries.

The report also includes detailed profiles of various end players, such as Merck KGaA, Wuxi Biologics (Cayman), Charles River Laboratories International Inc., Kedrion, Texcell Inc., Vironova Biosafety, Clean Cells, BSL BIOSERVICE Scientific Laboratories Munich GmbH, and ViruSure GmbH, among others.

This report segments the global viral clearance market as follows:

Global Viral Clearance Market: By Method

• Viral Removal 
  • Chromatography
  • Precipitation
  • Nanofiltration
• Viral Inactivation
  • Low pH
  • Solvent Detergent Method
  • Pasteurization
  • Other Viral Inactivation Methods

Global Viral Clearance Market: By Application

• Blood and Blood Products
• Recombinant Proteins
• Vaccines
• Other Applications (Stem Cell Products, Cellular & Gene Therapy Products, Tissue & Tissue Products, etc.)

Global Viral Clearance Market: By End-User

• Pharmaceutical & Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations (CROs)
• Other End-Users

Global Viral Clearance Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

Table Of Content

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research application
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Viral Clearance Market, 2015 - 2024 (USD Million)
  • 2.2. Global Viral Clearance Market: Snapshot
•  
• Chapter 3. Viral Clearance Market - Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Global Viral Clearance Market drivers: Impact analysis
    • 3.2.2. Growing Pharmaceutical and Biotechnology Industries
    • 3.2.3. Growth in biopharmaceutical drug launch
  • 3.3. Market Restraints
    • 3.3.1. High cost and time-consuming drug development application
  • 3.4. Opportunities
    • 3.4.1. Pharmaceutical outsourcing
  • 3.5. Porter's five forces analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. The threat from new entrants
    • 3.5.4. The threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by method segment
    • 3.6.2. Market attractiveness analysis, by application segment
    • 3.6.3. Market attractiveness analysis, by End-User segment
    • 3.6.4. Market attractiveness analysis, by regional segment
•  
• Chapter 4. Global Viral Clearance Market - Competitive Landscape
  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Viral Clearance Market: Company Market Share, 2017
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Product Launch
    • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
    • 4.2.4. Research and Development, Regional Expansion
•  
• Chapter 5. Global Viral Clearance Market - Method Segment Analysis
  • 5.1. Global Viral Clearance Market: Method overview
    • 5.1.1. Global Viral Clearance Market revenue share, by Method, 2017 and 2024
  • 5.2. Viral Removal
    • 5.2.1. Global Viral Clearance Market for Viral Removal, 2015 - 2024 (USD Million)
    • 5.2.2. Global Viral Clearance Market for Viral Removal by Chromatography, 2015 - 2024 (USD Million)
    • 5.2.3. Global Viral Clearance Market for Viral Removal by Precipitation, 2015 - 2024 (USD Million)
    • 5.2.4. Global Viral Clearance Market for Viral Removal by Nanofiltration, 2015 - 2024 (USD Million)
  • 5.3. Viral Inactivation
    • 5.3.1. Global Viral Clearance Market for Viral Inactivation, 2015 - 2024 (USD Million)
    • 5.3.2. Global Viral Clearance Market for Viral Inactivation by Low pH, 2015 - 2024 (USD Million)
    • 5.3.3. Global Viral Clearance Market for Viral Inactivation by Solvent Detergent Method, 2015 - 2024 (USD Million)
    • 5.3.4. Global Viral Clearance Market for Viral Inactivation by Pasteurization, 2015 - 2024 (USD Million)
    • 5.3.5. Global Viral Clearance Market for Viral Inactivation by Other Viral Inactivation Methods, 2015 - 2024 (USD Million)
•  
• Chapter 6. Global Viral Clearance Market - Application Segment Analysis
  • 6.1. Global Viral Clearance Market: Application segment overview
    • 6.1.1. Global Viral Clearance Market revenue share, by Application, 2017 and 2024
  • 6.2. Recombinant Proteins
    • 6.2.1. Global Viral Clearance Market for Recombinant Proteins, 2015 - 2024 (USD Million)
  • 6.3. Blood and Blood Products
    • 6.3.1. Global Viral Clearance Market for Blood and Blood Products, 2015 - 2024 (USD Million)
  • 6.4. Vaccines
    • 6.4.1. Global Viral Clearance Market for Vaccines, 2015 - 2024 (USD Million)
  • 6.5. Other Applications
    • 6.5.1. Global Viral Clearance Market for Other Applications, 2015 - 2024 (USD Million)
•  
• Chapter 7. Global Viral Clearance Market - End-User Segment Analysis
  • 7.1. Global Viral Clearance Market: End-User overview
    • 7.1.1. Global Viral Clearance Market revenue share, by End-User, 2017 and 2024
  • 7.2. Pharmaceutical & Biotechnology Companies
    • 7.2.1. Global Viral Clearance Market for Pharmaceutical & Biotechnology Companies, 2015 - 2024 (USD Million)
  • 7.3. Contract Research Organizations (CROs)
    • 7.3.1. Global Viral Clearance Market for Contract Research Organizations (CROs), 2015 - 2024 (USD Million)
  • 7.4. Academic Research Institutes
    • 7.4.1. Global Viral Clearance Market for Academic Research Institutes, 2015 - 2024 (USD Million)
  • 7.5. Other End-Users
    • 7.5.1. Global Viral Clearance Market for Other End-Users, 2015 - 2024 (USD Million)
•  
• Chapter 8. Global Viral Clearance Market - Regional Segment Analysis
  • 8.1. Global Viral Clearance Market: Regional overview
    • 8.1.1. Global Viral Clearance Market revenue share, by region, 2017 and 2024
  • 8.2. North America
    • 8.2.1. North America Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
    • 8.2.2. North America Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
    • 8.2.3. North America Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.2.4. The U.S.
      • 8.2.4.1. The U.S. Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.2.4.2. The U.S. Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.2.4.3. The U.S. Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.2.5. Canada
      • 8.2.5.1. Canada Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.2.5.2. Canada Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.2.5.3. Canada Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.2.6. Rest of North America
      • 8.2.6.1. Rest of North America Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.2.6.2. Rest of North America Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.2.6.3. Rest of North America Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
    • 8.3.2. Europe Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
    • 8.3.3. Europe Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Germany Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.3.4.2. Germany Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.3.4.3. Germany Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.3.5. U.K.
      • 8.3.5.1. U.K. Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.3.5.2. U.K. Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.3.5.3. U.K. Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.3.6. France
      • 8.3.6.1. France Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.3.6.2. France Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.3.6.3. France Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.3.7. Italy
      • 8.3.7.1. Italy Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.3.7.2. Italy Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.3.7.3. Italy Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.3.8. Spain
      • 8.3.8.1. Spain Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.3.8.2. Spain Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.3.8.3. Spain Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.3.9. Russia
      • 8.3.9.1. Russia Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.3.9.2. Russia Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.3.9.3. Russia Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.3.10. Rest of Europe
      • 8.3.10.1. Rest of Europe Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.3.10.2. Rest of Europe Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.3.10.3. Rest of Europe Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
    • 8.4.2. Asia Pacific Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
    • 8.4.3. Asia Pacific Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. China Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.4.4.2. China Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.4.4.3. China Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.4.5. Japan
      • 8.4.5.1. Japan Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.4.5.2. Japan Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.4.5.3. Japan Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.4.6. India
      • 8.4.6.1. India Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.4.6.2. India Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.4.6.3. India Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.4.7. Australia
      • 8.4.7.1. Australia Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.4.7.2. Australia Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.4.7.3. Australia Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.4.8. Rest of Asia Pacific
      • 8.4.8.1. Rest of Asia Pacific Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.4.8.2. Rest of Asia Pacific Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.4.8.3. Rest of Asia Pacific Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
    • 8.5.2. Latin America Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
    • 8.5.3. Latin America Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.5.4. Brazil
      • 8.5.4.1. Brazil Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.5.4.2. Brazil Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.5.4.3. Brazil Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.5.5. Mexico
      • 8.5.5.1. Mexico Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.5.5.2. Mexico Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.5.5.3. Mexico Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.5.6. Argentina
      • 8.5.6.1. Argentina Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.5.6.2. Argentina Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.5.6.3. Argentina Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.5.7. Rest of Latin America
      • 8.5.7.1. Rest of Latin America Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.5.7.2. Rest of Latin America Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.5.7.3. Rest of Latin America Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
    • 8.6.2. The Middle East and Africa Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
    • 8.6.3. The Middle East and Africa Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Saudi Arabia Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.6.4.2. Saudi Arabia Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.6.4.3. Saudi Arabia Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. UAE Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.6.5.2. UAE Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.6.5.3. UAE Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.6.6. South Africa
      • 8.6.6.1. South Africa Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.6.6.2. South Africa Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.6.6.3. South Africa Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.6.7. Qatar
      • 8.6.7.1. Qatar Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.6.7.2. Qatar Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.6.7.3. Qatar Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
    • 8.6.8. Rest of the Middle East and Africa
      • 8.6.8.1. Rest of the Middle East and Africa Viral Clearance Market revenue, by Method, 2015 - 2024 (USD Million)
      • 8.6.8.2. Rest of the Middle East and Africa Viral Clearance Market revenue, by Application, 2015 - 2024 (USD Million)
      • 8.6.8.3. Rest of the Middle East and Africa Viral Clearance Market revenue, by End-User, 2015 - 2024 (USD Million)
•  
• Chapter 9. Company Profile
  • 9.1. Merck KGaA
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Therapy portfolio
    • 9.1.4. Business strategy
    • 9.1.5. Recent developments
  • 9.2. Wuxi Biologics (Cayman)
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Therapy portfolio
    • 9.2.4. Business strategy
    • 9.2.5. Recent developments
  • 9.3. Charles River Laboratories International Inc.
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Therapy portfolio
    • 9.3.4. Business strategy
    • 9.3.5. Recent developments
  • 9.4. Kedrion
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Therapy portfolio
    • 9.4.4. Business strategy
    • 9.4.5. Recent developments
  • 9.5. Texcell Inc.
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Therapy portfolio
    • 9.5.4. Business strategy
    • 9.5.5. Recent developments
  • 9.6. Vironova Biosafety
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Therapy portfolio
    • 9.6.4. Business strategy
    • 9.6.5. Recent developments
  • 9.7. Clean Cells
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Therapy portfolio
    • 9.7.4. Business strategy
    • 9.7.5. Recent developments
  • 9.8. BSL BIOSERVICE Scientific Laboratories Munich GmbH
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Therapy portfolio
    • 9.8.4. Business strategy
    • 9.8.5. Recent developments
  • 9.9. ViruSure GmbH
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Therapy portfolio
    • 9.9.4. Business strategy
    • 9.9.5. Recent developments

Methodology

Free Analysis

Animal cell culture techniques are widely used for the production of biologics, such as recombinant proteins, vaccines, tissue products, etc. Microbiological safety of these products plays an important role. These products are prone to microbial contamination, such as bacteria, fungi, mycoplasma, yeasts, and viruses. Microbial contamination with bacteria, fungi, and yeasts can be easily detected. Viral contaminations pose a serious concern and require specific detection methods. Some sources of viral infection are contaminated raw materials, contaminated cell lines, GMP breakdown from the purification process, or improper cell line handling. Highly nutrient-rich medium is required for culturing animal cells. Nutrient-rich medium attracts microorganisms and their spores, and, in turn, might infect the cultured cells compromising growth and characteristics in the culture medium. This would adversely affect the quality of therapeutic products, biologics, etc.

In order to produce microbiologically safe products, viral and other contaminants need to be removed or inactivated. Viral clearance is one of the most important processes during the purification of biologics. Viruses are cleared either by removal or inactivation. Virus removal is performed via chromatography, precipitation, and nanofiltration. Viral inactivation is conducted using low pH method, solvent detergent method, pasteurization, etc.

Recombinant proteins have high potency and lesser side effects. They mimic naturally occurring proteins and, hence, are widely used worldwide. Thus, the growth is observed in the biopharmaceutical research and development field. Advances and investments made in the biotechnology and pharmaceutical industries drive the viral clearance market. Additionally, favorable research funding and government grants for product development contribute notably toward this market’s growth. The need for virus clearance in cell culture to avoid contamination, high burden of chronic disorders, and increasing aging population are also likely to contribute toward the viral clearance market. The high cost of technology and the time-consuming process of drug development might hamper this market’s growth. Growing demand for contract research organizations for pharmaceutical outsourcing along with potential emerging markets are likely to present lucrative opportunities for the viral clearance market in the upcoming years. 

The viral clearance market is divided based on viral clearance method, application, and end-user. The viral clearance method segment is categorized into viral removal and viral inactivation. Viral removal segment is sub-segmented into chromatography, precipitation, and nanofiltration based on virus removal technique. The viral inactivation segment is sub-segmented into low pH, solvent detergent method, pasteurization, and other viral inactivation methods. In the viral removal segment, nanofiltration held the largest market share in 2017. Chromatographic viral removal segment is expected to grow at the fastest CAGR. By application, the viral clearance market is segmented into blood and blood products, recombinant proteins, vaccines, and other applications. The other applications include stem cell products, cellular and gene therapy products, tissue and tissue products etc. The recombinant proteins application segment dominated the market in 2017, owing to increased production and use of biosimilars and other therapeutic proteins for treating life-threatening diseases, such as cancer, diabetes, etc., globally. By end-user, this market includes pharmaceutical and biotechnology companies, academic research institutes, contract research organizations (CROs), and other end-users. The pharmaceutical and biotechnology companies segment dominated the viral clearance market in 2017 in terms of revenue share and is projected to lead during the forecast time period.

In 2017, the leading regional market in terms of revenue share was North America. This was due to developed R&D infrastructure, growth in stem cell research, gene therapy and R&D activities in the biopharmaceutical sector act in the region. North America is likely to maintain its leading position in the forecast time period. The second largest market in terms of revenue share was Europe in 2017, due to the high acceptance of viral clearance methods for various applications, such as gene therapy, stem cell research, and biopharmaceuticals. The Asia Pacific is a rapidly growing region, due to generic manufacturing and development in India and the presence of many CROs in China and India. The Middle Eastern and African region is expected to witness a considerable rate of growth in the upcoming years. Latin America is projected to exhibit moderate growth during the forecast time period.

Some key players operating in the viral clearance market include Merck KGaA, Wuxi Biologics (Cayman), Charles River Laboratories International Inc., Kedrion, Texcell Inc., Vironova Biosafety, Clean Cells, BSL BIOSERVICE Scientific Laboratories Munich GmbH, and ViruSure GmbH, among others.